CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Commercial Officer sold 11,890 shares at $1.87 ($22,230)
- 8-K Event Agreement ended
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Patient Supply Officer sold 4,440 shares at $1.86 ($8,250)
- 4 Open-market sale Chief Operating Officer sold 4,440 shares at $1.86 ($8,250)
- 4 Open-market sale Chief Medical Officer sold 2,159 shares at $1.86 ($4,011)
- 4 Open-market sale Chief Executive Officer sold 10,057 shares at $1.86 ($18,686)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 8,816 shares at an average $1.72 ($15,197)
- 4 Open-market sale Chief Patient Supply Officer sold 8,816 shares at an average $1.72 ($15,197)
Page 11 of 41 · 808 filings